- Home
- FMBH vs ORIC Comparison
FMBH vs ORIC Comparison
Compare FMBH & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMBH
- ORIC
- Stock Information
- Founded
- FMBH 1865
- ORIC 2014
- Country
- FMBH United States
- ORIC United States
- Employees
- FMBH N/A
- ORIC N/A
- Industry
- FMBH Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- FMBH Finance
- ORIC Health Care
- Exchange
- FMBH Nasdaq
- ORIC Nasdaq
- Market Cap
- FMBH 920.6M
- ORIC 750.6M
- IPO Year
- FMBH N/A
- ORIC 2020
- Fundamental
- Price
- FMBH $41.99
- ORIC $8.50
- Analyst Decision
- FMBH Buy
- ORIC Strong Buy
- Analyst Count
- FMBH 5
- ORIC 9
- Target Price
- FMBH $43.40
- ORIC $18.75
- AVG Volume (30 Days)
- FMBH 63.7K
- ORIC 499.8K
- Earning Date
- FMBH 10-31-2024
- ORIC 11-12-2024
- Dividend Yield
- FMBH 2.29%
- ORIC N/A
- EPS Growth
- FMBH N/A
- ORIC N/A
- EPS
- FMBH 3.24
- ORIC N/A
- Revenue
- FMBH $316,387,000.00
- ORIC N/A
- Revenue This Year
- FMBH N/A
- ORIC N/A
- Revenue Next Year
- FMBH $4.32
- ORIC N/A
- P/E Ratio
- FMBH $12.94
- ORIC N/A
- Revenue Growth
- FMBH 22.37
- ORIC N/A
- 52 Week Low
- FMBH $28.86
- ORIC $6.33
- 52 Week High
- FMBH $43.52
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- FMBH 58.60
- ORIC 37.50
- Support Level
- FMBH $41.29
- ORIC $10.06
- Resistance Level
- FMBH $43.52
- ORIC $11.11
- Average True Range (ATR)
- FMBH 1.30
- ORIC 0.81
- MACD
- FMBH 0.27
- ORIC -0.05
- Stochastic Oscillator
- FMBH 77.86
- ORIC 13.00
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. It also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.